Published in Clin Exp Immunol on August 01, 2000
Genetic partitioning of interleukin-6 signalling in mice dissociates Stat3 from Smad3-mediated lung fibrosis. EMBO Mol Med (2012) 1.07
Expression of vascular adhesion protein-1 in normal and inflamed mice lungs and normal human lungs. Virchows Arch (2003) 0.94
Lymphocyte homing and homeostasis. Science (1996) 13.26
A central role for microvillous receptor presentation in leukocyte adhesion under flow. Cell (1995) 2.89
Evidence for an accessory role of LFA-1 in lymphocyte-high endothelium interaction during homing. J Immunol (1988) 2.74
Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine-activated killer cells. J Exp Med (1989) 2.33
P-selectin/ICAM-1 double mutant mice: acute emigration of neutrophils into the peritoneum is completely absent but is normal into pulmonary alveoli. J Clin Invest (1995) 2.02
Characterization of the rat leukocyte integrin, CD11/CD18, by the use of LFA-1 subunit-specific monoclonal antibodies. Eur J Immunol (1991) 1.90
Leukocyte migration and adhesion. Adv Immunol (1995) 1.62
Heparin inhibits ligand binding to the leukocyte integrin Mac-1 (CD11b/CD18). Circulation (1999) 1.58
How do lymphocytes know where to go: current concepts and enigmas of lymphocyte homing. Adv Immunol (1997) 1.43
Role of the intercellular adhesion molecule-1(ICAM-1) in endotoxin-induced pneumonia evaluated using ICAM-1 antisense oligonucleotides, anti-ICAM-1 monoclonal antibodies, and ICAM-1 mutant mice. J Clin Invest (1996) 1.38
Staphylococcal alpha-toxin-induced vascular leakage in isolated perfused rabbit lungs. Lab Invest (1990) 1.35
Leukocyte traffic in the lung. Annu Rev Physiol (1995) 1.32
The recirculating lymphocyte pool of the rat: a systematic description of the migratory behaviour of recirculating lymphocytes. Immunology (1983) 1.27
Circulating activated platelets reconstitute lymphocyte homing and immunity in L-selectin-deficient mice. J Exp Med (1998) 1.09
Evidence of a selective major vascular marginal pool of lymphocytes in the lung. Am Rev Respir Dis (1987) 1.09
The fate of activated T cells migrating through the body: rescue from apoptosis in the tissue of origin. Eur J Immunol (1997) 1.01
CD4+ T cells of both the naive and the memory phenotype enter rat lymph nodes and Peyer's patches via high endothelial venules: within the tissue their migratory behavior differs. Eur J Immunol (1997) 0.96
Induction of severe vascular leakage by low doses of Escherichia coli hemolysin in perfused rabbit lungs. Lab Invest (1992) 0.95
Lymphocytes in the lung: an often neglected cell. Numbers, characterization and compartmentalization. Anat Embryol (Berl) (1995) 0.93
IFN-gamma influences the migration of thoracic duct B and T lymphocyte subsets in vivo. Random increase in disappearance from the blood and differential decrease in reappearance in the lymph. J Immunol (1993) 0.92
LFA-1 and L-selectin regulation of recirculating lymphocyte tethering and rolling on lung microvascular endothelium. Am J Respir Cell Mol Biol (1996) 0.92
Characterization of the RT-Ly-1 and RT-Ly-2 alloantigenic systems by congenic rat strains. Transplant Proc (1979) 0.91
Compartmentalization and kinetics of lymphoid cells in the lung. Reg Immunol (1990) 0.89
Adult respiratory distress syndrome: model systems using isolated perfused rabbit lungs. Methods Enzymol (1994) 0.86
Roles of adhesion molecules ICAM-1 and alpha4 integrin in antigen-induced changes in microvascular permeability associated with lung inflammation in sensitized brown Norway rats. Am J Respir Cell Mol Biol (1997) 0.84
Leukocyte kinetics in the pulmonary microcirculation: observations using real-time confocal luminescence microscopy coupled with high-speed video analysis. Lab Invest (1997) 0.84
Adhesion molecule expression in the lung: a comparison between normal and diffuse interstitial lung disease. Eur Respir J (1998) 0.83
Dendritic cell precursors are enriched in the vascular compartment of the lung. Am J Respir Cell Mol Biol (1998) 0.82
Distinct expression of cell-cell and cell-matrix adhesion molecules on endothelial cells in human heart and lung transplants. J Heart Lung Transplant (1996) 0.82
Role of endothelial cytoskeleton in high-permeability edema due to botulinum C2 toxin in perfused rabbit lungs. Am J Physiol (1995) 0.82
Role of intercellular adhesion molecule-1 in antigen-induced lung inflammation in brown Norway rats. Am J Physiol (1996) 0.81
Vasoregulatory prostanoid generation proceeds via cyclooxygenase-2 in noninflamed rat lungs. J Pharmacol Exp Ther (1998) 0.80
Changes in adhesion molecule expression during distinct patterns of immune cell migration in the inflamed lung. Arch Histol Cytol (1996) 0.80
Blood leucocyte subsets of the rat: expression of adhesion molecules and localization within high endothelial venules. Scand J Immunol (1996) 0.80
Heparin regulates ICAM-1 expression in human endothelial cells: an example of non-cytokine-mediated endothelial activation. Thromb Haemost (1998) 0.80
Morphometric analysis of pulmonary intracapillary leukocyte pools in ex vivo-perfused rabbit lungs. Am J Physiol (1994) 0.79
Increased expression of activation markers and adhesion molecules on lung T-cells compared with blood in the normal rat. Eur Respir J (1999) 0.79
Comparison of lymphocyte subsets, monocytes, and NK cells in three different lung compartments and peripheral blood in the rat. Exp Lung Res (1997) 0.78
The lung as a source and a target organ for T- and B-lymphocytes. Am J Respir Cell Mol Biol (1997) 0.77
Neutrophil passage through isolated perfused rabbit lungs. Am J Physiol (1991) 0.76
Real-time quantitative RT-PCR after laser-assisted cell picking. Nat Med (1998) 7.34
Terminology: nomenclature of mucosa-associated lymphoid tissue. Mucosal Immunol (2008) 5.28
The carina as a landmark in central venous catheter placement. Br J Anaesth (2000) 4.12
[The path to "Doctor of Medicine"--how do doctoral candidates evaluate their dissertation?]. Dtsch Med Wochenschr (1998) 2.95
How organ-specific is the migration of 'naive' and 'memory' T cells? Immunol Today (1996) 2.68
Sildenafil treatment for portopulmonary hypertension. Eur Respir J (2006) 2.58
Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med (2000) 2.55
Treprostinil inhibits the recruitment of bone marrow-derived circulating fibrocytes in chronic hypoxic pulmonary hypertension. Eur Respir J (2010) 2.51
Lymphocyte subsets in the blood: a diagnostic window on the lymphoid system? Immunol Today (1990) 2.50
Neoalveolarisation contributes to compensatory lung growth following pneumonectomy in mice. Eur Respir J (2007) 2.11
Alveolar fibrin formation caused by enhanced procoagulant and depressed fibrinolytic capacities in severe pneumonia. Comparison with the acute respiratory distress syndrome. Am J Respir Crit Care Med (2000) 1.95
[The medical dissertation--no definitive model. Results of a survey about obtaining a doctorate contradict frequently stated opinions]. Dtsch Med Wochenschr (2003) 1.91
Monocytes recruited into the alveolar air space of mice show a monocytic phenotype but upregulate CD14. Am J Physiol Lung Cell Mol Physiol (2001) 1.85
Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema. Am J Respir Crit Care Med (1996) 1.79
Commercial versus native surfactants. Surface activity, molecular components, and the effect of calcium. Am J Respir Crit Care Med (2000) 1.78
Aerosolised prostacyclin in adult respiratory distress syndrome. Lancet (1993) 1.74
A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension. German PPH study group. J Am Coll Cardiol (2000) 1.73
Cell renewal of glomerular cell types in normal rats. An autoradiographic analysis. Kidney Int (1983) 1.71
The dorsolateral, suboccipital, transcondylar approach to the lower clivus and anterior portion of the craniocervical junction. Neurosurgery (1991) 1.67
Inhibition of phosphodiesterase 4 enhances lung alveolarisation in neonatal mice exposed to hyperoxia. Eur Respir J (2008) 1.62
Bacterial exotoxins and endothelial permeability for water and albumin in vitro. Am J Physiol (1988) 1.61
Expression and function of soluble guanylate cyclase in pulmonary arterial hypertension. Eur Respir J (2008) 1.58
Staphylococcal alpha-toxin-induced PGI2 production in endothelial cells: role of calcium. Am J Physiol (1985) 1.57
Inhaled iloprost to treat severe pulmonary hypertension. An uncontrolled trial. German PPH Study Group. Ann Intern Med (2000) 1.57
Dendritic cells in the mucosa of the human trachea are not regularly found in the first year of life. Thorax (2001) 1.55
Phenotypic characterization of alveolar monocyte recruitment in acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol (2000) 1.54
Receptor for advanced glycation endproducts (RAGE) exhibits highly differential cellular and subcellular localisation in rat and human lung. Cell Mol Biol (Noisy-le-grand) (1998) 1.52
[Sildenafil for treatment of severe pulmonary hypertension and commencing right-heart failure]. Pneumologie (2002) 1.48
M cells in Peyer's patches of the intestine. Int Rev Cytol (1996) 1.47
Terguride ameliorates monocrotaline-induced pulmonary hypertension in rats. Eur Respir J (2010) 1.47
Alteration of surfactant function due to protein leakage: special interaction with fibrin monomer. J Appl Physiol (1985) (1985) 1.44
Staphylococcal alpha-toxin elicits hypertension in isolated rabbit lungs. Evidence for thromboxane formation and the role of extracellular calcium. J Clin Invest (1984) 1.43
Biosynthesis of constitutive nitric oxide synthase-derived nitric oxide attenuates coronary vasoconstriction and myocardial depression in a model of septic heart failure induced by Staphylococcus aureus alpha-toxin. Crit Care Med (2001) 1.43
Pulmonary periarterial inflammation in fatal asthma. Clin Exp Allergy (2009) 1.42
Aerosolized prostacyclin and iloprost in severe pulmonary hypertension. Ann Intern Med (1996) 1.42
Characterisation of post-pneumonectomy lung growth in adult mice. Eur Respir J (2004) 1.39
Nano-carriers for DNA delivery to the lung based upon a TAT-derived peptide covalently coupled to PEG-PEI. J Control Release (2005) 1.38
Bronchus-associated lymphoid tissue (BALT) is not present in the normal adult lung but in different diseases. Pathobiology (2000) 1.38
Distribution of lymphocyte subsets and natural killer cells in the human body. Clin Investig (1992) 1.38
The effect of repeated ozone exposures on inflammatory markers in bronchoalveolar lavage fluid and mucosal biopsies. Am J Respir Crit Care Med (2000) 1.36
Bronchoalveolar and systemic cytokine profiles in patients with ARDS, severe pneumonia and cardiogenic pulmonary oedema. Eur Respir J (1996) 1.35
Staphylococcal alpha-toxin-induced vascular leakage in isolated perfused rabbit lungs. Lab Invest (1990) 1.35
Bronchoscopic administration of bovine natural surfactant in ARDS and septic shock: impact on biophysical and biochemical surfactant properties. Eur Respir J (2002) 1.35
Complement factors C3a and C5a are increased in bronchoalveolar lavage fluid after segmental allergen provocation in subjects with asthma. Am J Respir Crit Care Med (2001) 1.34
Enhanced tissue factor pathway activity and fibrin turnover in the alveolar compartment of patients with interstitial lung disease. Thromb Haemost (2000) 1.33
Monocyte migration through the alveolar epithelial barrier: adhesion molecule mechanisms and impact of chemokines. J Immunol (2000) 1.32
Mechanism of leukotriene generation in polymorphonuclear leukocytes by staphylococcal alpha-toxin. Infect Immun (1987) 1.30
In vivo labelling of the spleen and mesenteric lymph nodes with fluorescein isothiocyanate for lymphocyte migration studies. Immunology (1981) 1.30
Bronchoscopic administration of bovine natural surfactant in ARDS and septic shock: impact on gas exchange and haemodynamics. Eur Respir J (2002) 1.27
Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea: response to CPAP therapy. Thorax (2000) 1.27
Surfactant abnormalities in patients with respiratory failure after multiple trauma. Am Rev Respir Dis (1989) 1.27
Morphology and immunology of the human palatine tonsil. Anat Embryol (Berl) (2001) 1.24
Regulation of hypoxic pulmonary vasoconstriction: basic mechanisms. Eur Respir J (2008) 1.24
Surfactant alteration and replacement in acute respiratory distress syndrome. Respir Res (2001) 1.23
Human endothelial cell activation and mediator release in response to the bacterial exotoxins Escherichia coli hemolysin and staphylococcal alpha-toxin. J Immunol (1997) 1.23
HIV-induced decline in blood CD4/CD8 ratios: viral killing or altered lymphocyte trafficking? Immunol Today (1998) 1.22
Hypoxic vasoconstriction in intact lungs: a role for NADPH oxidase-derived H(2)O(2)? Am J Physiol Lung Cell Mol Physiol (2000) 1.22
The temporal relationship between glomerular cell proliferation and monocyte infiltration in experimental glomerulonephritis. Virchows Arch B Cell Pathol Incl Mol Pathol (1982) 1.21
Alveolar JE/MCP-1 and endotoxin synergize to provoke lung cytokine upregulation, sequential neutrophil and monocyte influx, and vascular leakage in mice. Am J Respir Crit Care Med (2001) 1.21
Cloning and characterization of gp36, a human mucin-type glycoprotein preferentially expressed in vascular endothelium. Biochem J (1999) 1.21
Airway exposure to bacterial superantigen (SEB) induces lymphocyte-dependent airway inflammation associated with increased airway responsiveness--a model for non-allergic asthma. Eur J Immunol (1999) 1.20
Investigation of the proinflammatory potential of biodegradable nanoparticle drug delivery systems in the lung. Toxicol Appl Pharmacol (2006) 1.19
Classification of lymphocytes recirculating in the spleen. Immunology (1981) 1.19
Lymphocytes in the bronchoalveolar space reenter the lung tissue by means of the alveolar epithelium, migrate to regional lymph nodes, and subsequently rejoin the systemic immune system. Anat Rec (2001) 1.18
The listerial exotoxins listeriolysin and phosphatidylinositol-specific phospholipase C synergize to elicit endothelial cell phosphoinositide metabolism. J Immunol (1996) 1.17
[Bilateral occurrence of a. brachialis superficialis, a. ulnaris superficialis and a. mediana]. Anat Anz (1968) 1.17
A codominant role of Fc gamma RI/III and C5aR in the reverse Arthus reaction. J Immunol (2000) 1.17
Human endothelial cell activation and mediator release in response to Listeria monocytogenes virulence factors. Infect Immun (2001) 1.16
Microsurgical unilateral approaches for spinal tumour surgery: eight years' experience in 256 primary operated patients. Acta Neurochir (Wien) (1989) 1.16
Effects of Escherichia coli hemolysin on endothelial cell function. Infect Immun (1990) 1.16
The anatomical basis for the immune function of the gut. Anat Embryol (Berl) (1987) 1.16
Escherichia coli hemolysin is a potent inductor of phosphoinositide hydrolysis and related metabolic responses in human neutrophils. J Clin Invest (1991) 1.13
Noncytolytic terminal complement complexes may serve as calcium gates to elicit leukotriene B4 generation in human polymorphonuclear leukocytes. J Immunol (1986) 1.13
Alteration of fatty acid profiles in different pulmonary surfactant phospholipids in acute respiratory distress syndrome and severe pneumonia. Am J Respir Crit Care Med (2001) 1.13
Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis. Am J Respir Crit Care Med (1999) 1.13
Neutrophil activation by anti-proteinase 3 antibodies in Wegener's granulomatosis: role of exogenous arachidonic acid and leukotriene B4 generation. J Exp Med (1996) 1.12
Endotoxin-induced myocardial tumor necrosis factor-alpha synthesis depresses contractility of isolated rat hearts: evidence for a role of sphingosine and cyclooxygenase-2-derived thromboxane production. Circulation (2000) 1.12
Parkinsonism and rest tremor secondary to supratentorial tumours sparing the basal ganglia. Acta Neurochir (Wien) (1995) 1.12
Ex vivo antigen preparation for the serological detection of drug-dependent antibodies in immune haemolytic anaemias. Br J Haematol (1984) 1.11
Proinflammatory cytokines trigger MUC gene expression and mucin release in the intestinal cancer cell line LS180. Inflamm Res (2000) 1.11
Transfusion-related acute lung injury due to HLA-A2-specific antibodies in recipient and NB1-specific antibodies in donor blood. Br J Haematol (1996) 1.10
SNAI transcription factors mediate epithelial-mesenchymal transition in lung fibrosis. Thorax (2009) 1.10
Listeriolysin is a potent inducer of the phosphatidylinositol response and lipid mediator generation in human endothelial cells. Infect Immun (1996) 1.09
Phosphodiesterase-4 promotes proliferation and angiogenesis of lung cancer by crosstalk with HIF. Oncogene (2012) 1.09
Kinetics of particle uptake in the domes of Peyer's patches. Am J Physiol (1998) 1.09
Blood transit and recirculation kinetics of lymphocyte subsets in normal rats. Scand J Immunol (1988) 1.08
The hemolysin of Escherichia coli. Eur J Epidemiol (1988) 1.07
Lymphocytes migrate from the blood into the bronchoalveolar lavage and lung parenchyma in the asthma model of the brown Norway rat. Am J Respir Crit Care Med (2000) 1.07
Bronchus-associated lymphoid tissue (BALT) in the lungs of children who had died from sudden infant death syndrome and other causes. Thorax (1995) 1.07
Proliferation of lymphocyte subsets in the adult rat: a comparison of different lymphoid organs. Eur J Immunol (1989) 1.06
Evidence for the existence of two distinct types of Peyer's patches in sheep. Adv Exp Med Biol (1985) 1.06
Pulmonary surfactant: functions, abnormalities and therapeutic options. Intensive Care Med (2001) 1.06
The spleen in lymphocyte migration. Immunol Today (1988) 1.06